Zhihong Chi

6.8k citations
171 papers · 3.6k indexed · 1 hit paper · h-index 34
Topics
Cutaneous Melanoma Detection and Management (52 papers)Cancer Immunotherapy and Biomarkers (47 papers)Melanoma and MAPK Pathways (45 papers)

In The Last Decade

Zhihong Chi

162 papers receiving 3.6k citations

Hit Papers

Open-label, Multicenter, Phase II Study of RC48-ADC, a HE...2020202620222024202050100150

Peers

Zhihong Chi
Comparison fields: 5 of 120
  • Oncology 1.9k
  • Molecular Biology 1.7k
  • Immunology 679
  • Cancer Research 426
  • Pulmonary and Respiratory Medicine 401
Replace Lise Binderup with:
Lise Binderup Denmark
Franca Stivala Italy
Paweł Surowiak Poland
Joseph A. Fontana United States
Concetta Bubici United States
Camilla Evangelisti Italy
Jörg Bäsecke Germany
Peeter Karihtala Finland
Valentina M. Factor United States
Claudio Festuccia Italy
Zhihong Chi relative to Lise Binderup Denmark Lise Binderup's profile →
Citations per field
00.5×10.0×
Lise Binderup · 1×
Citations per year

Countries citing papers authored by Zhihong Chi

Since Specialization
Citations

This map shows the geographic impact of Zhihong Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihong Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihong Chi more than expected).

Fields of papers citing papers by Zhihong Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihong Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihong Chi. The network helps show where Zhihong Chi may publish in the future.

Co-authorship network of co-authors of Zhihong Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihong Chi. A scholar is included among the top collaborators of Zhihong Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihong Chi. Zhihong Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 1
4 4
5 2
6 6
7 38
8 33
9 6
10 26
11 36
12 61
13 1
14 72
15 58
16 35
17 38
18 121
19 181
20 2

About Zhihong Chi

Zhihong Chi is a scholar working on Oncology, Immunology and Nutrition and Dietetics, having authored 171 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (52 papers), Cancer Immunotherapy and Biomarkers (47 papers) and Melanoma and MAPK Pathways (45 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (679 citations) and Cancer Research (426 citations). Zhihong Chi has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Lu Si, Chuanliang Cui, Xinan Sheng, Jun Guo, Yan Kong, Lili Mao, Bixia Tang, Bin Lian, Jie Dai and Zhan‐You Wang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026